VI
Vivamed, Inc.
SEC filingBiotechnology · Santa Monica, CA
Amount raised$3Msold at filing
Total offering$3M
Investors in the raise1count reported to the SEC
FiledMay 27, 2026first sale May 18, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Aydin BabakhaniExecutive Officer, Director
Sepideh NouriExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.